
Monday, November 29, 2021 2:25:06 PM
Recent KRYS News
- Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2025 09:12:19 PM
- Krystal Biotech to Present at BofA Securities 2025 Health Care Conference • GlobeNewswire Inc. • 05/07/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 12:09:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2025 12:08:58 PM
- Krystal Biotech Announces First Quarter 2025 Financial and Operating Results • GlobeNewswire Inc. • 05/06/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2025 12:53:15 PM
- Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa • GlobeNewswire Inc. • 04/28/2025 11:00:00 AM
- Krystal Biotech to Present at Upcoming Scientific Conferences • GlobeNewswire Inc. • 04/24/2025 12:00:00 PM
- Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025 • GlobeNewswire Inc. • 04/17/2025 12:00:00 PM
- Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer • GlobeNewswire Inc. • 04/07/2025 08:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/03/2025 08:44:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2025 08:38:54 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2025 08:38:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2025 12:01:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2025 09:53:40 PM
- Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa • GlobeNewswire Inc. • 02/28/2025 12:40:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2025 04:52:59 PM
- Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference • GlobeNewswire Inc. • 02/26/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 12:25:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/19/2025 12:19:55 PM
- Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results • GlobeNewswire Inc. • 02/19/2025 12:00:00 PM
- Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 • GlobeNewswire Inc. • 02/06/2025 01:00:00 PM
- Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer • GlobeNewswire Inc. • 01/14/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 01:39:33 PM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM